Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases

被引:71
|
作者
Ali, Simak [1 ]
Buluwela, Laki [1 ]
Coombes, R. Charles [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Oncol, Div Canc, London W12 0NN, England
来源
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 | 2011年 / 62卷
关键词
estrogen; breast cancer; selective estrogen receptor modulators (SERMs); cancer prevention; ESTROGEN-RECEPTOR-ALPHA; HEALTHY POSTMENOPAUSAL WOMEN; SURGICAL ADJUVANT BREAST; CELL-CYCLE PROGRESSION; HEART-DISEASE; TRANSCRIPTIONAL ACTIVATION; REPRODUCTIVE FUNCTION; NUCLEAR RECEPTORS; PLUS PROGESTIN; BOWEL PROJECT;
D O I
10.1146/annurev-med-052209-100305
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The identification of the link between breast cancer and estrogens has led to the development of antiestrogens, in particular tamoxifen, to inhibit the activities of estrogen receptors (ERs) in breast cancer cells. The clinical use of tamoxifen has played a major part in decreasing breast cancer mortality over the past 30 years. Though antiestrogenic in the breast, some antiestrogens have estrogen-like actions in other tissues, acting to promote bone density and protect against cardiovascular disease, thus raising the possibility of their use in counteracting the effects of estrogen loss following menopause. Moreover, antiestrogens show efficacy as chemopreventive agents in women at high risk of developing breast cancer. Thus, antiestrogens define an important and well-understood class of cancer drug, which continue to be a mainstay in breast cancer treatment.
引用
收藏
页码:217 / 232
页数:16
相关论文
共 50 条
  • [41] Fucoidan as an Autophagy Regulator: Mechanisms and Therapeutic Potentials for Cancer and Other Diseases
    Zhang, Nan
    Xue, Meilan
    Sun, Ting
    Yang, Jia
    Pei, Zhongqian
    Qin, Kunpeng
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (05): : 1568 - 1579
  • [42] Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
    Marquez-Garban, Diana C.
    Deng, Gang
    Comin-Anduix, Begonya
    Garcia, Alejandro J.
    Xing, Yanpeng
    Chen, Hsiao-Wang
    Cheung-Lau, Gardenia
    Hamilton, Nalo
    Jung, Michael E.
    Pietras, Richard J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 193
  • [43] Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
    Kandouz, M
    Lombet, A
    Perrot, JY
    Jacob, D
    Carvajal, S
    Kazem, A
    Rostene, W
    Therwath, A
    Gompel, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6): : 463 - 471
  • [44] The estrogen receptor: A logical target for the prevention of breast cancer with antiestrogens
    Tonetti, DA
    Jordan, VC
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (04) : 401 - 413
  • [45] Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells
    Rajah, TT
    Pento, JT
    CANCER INVESTIGATION, 1999, 17 (01) : 10 - 18
  • [46] The Estrogen Receptor: A Logical Target for the Prevention of Breast Cancer with Antiestrogens
    Debra A. Tonetti
    V. Craig Jordan
    Journal of Mammary Gland Biology and Neoplasia, 1999, 4 : 401 - 413
  • [47] THE FUTURE OF NEW PURE ANTIESTROGENS IN CLINICAL BREAST-CANCER
    WAKELING, AE
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 25 (01) : 1 - 9
  • [49] DROLOXIFENE - ADVANCES IN THE TREATMENT OF BREAST-CANCER WITH ANTIESTROGENS - INTRODUCTION
    POSSINGER, K
    ONKOLOGIE, 1994, 17 : 5 - 5
  • [50] STEROIDAL AND NONSTEROIDAL ANTIESTROGENS IN BREAST-CANCER CELLS IN CULTURE
    ROCHEFORT, H
    BARDON, S
    CHALBOS, D
    VIGNON, F
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (01): : 105 - 110